Data integrity lapses at Strides’s Puducherry plant; USFDA may widen scrutiny

Data integrity lapses at Strides’s Puducherry plant; USFDA may widen scrutiny The warning letter addressed to Arun Kumar, CEO and MD of the company, was issued on July 1 said its investigator found a blue binder containing CGMP records, including batch records for US drug products, discarded with other records in a 55-gallon drum in the scrap yard

No comments:

Post a Comment